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Claudia Lucia de Moraes Forjaz,3 Pedro Puech-Le~ao,1 and Nelson Wolosker,1
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Background: The objective of this study was to analyze the muscle strength and endurance of
the proximal and distal lower-extremity muscles in peripheral artery disease (PAD) patients.
Methods: Twenty patients with bilateral PAD with symptoms of intermittent claudication and
nine control subjects without PAD were included in the study, comprising 40 and 18 legs,
respectively. All subjects performed an isokinetic muscle test to evaluate the muscle strength
and endurance of the proximal (knee extension and knee flexion movements) and distal (plantar
flexion and dorsiflexion movements) muscle groups in the lower extremity.
Results: Compared with the control group, the PAD group presented lower muscle strength in
knee flexion (14.0%), dorsiflexion (26.0%), and plantar flexion (21.2%) movements
(P < 0.05) but similar strength in knee extension movements (P > 0.05). The PAD patients pre-
sented a 13.5% lower knee flexion/extension strength ratio compared with the control subjects
(P < 0.05), as well as lower muscle endurance in dorsiflexion (28.1%) and plantar flexion
(17.0%) movements (P < 0.05). The muscle endurance in knee flexion and knee extension
movements was similar between PAD patients and the control subjects (P > 0.05).
Conclusion: PAD patients present lower proximal and distal muscle strength and lower distal
muscle endurance than control patients. Therefore, interventions to improve muscle strength
and endurance should be prescribed for PAD patients.
INTRODUCTION
Peripheral artery disease (PAD) affects more than
12% of the population >65 years in age,1 and the
most common cause is the chronic atherosclerotic
process, which decreases the oxygen supply to the
lower limbs.1 As a consequence, most PAD patients
present claudication symptoms, leading to impaired
walking ability.2,3
The aging process results in decreased muscle
function,4,5 which has been associated with an
increased risk of falls,6,7 leading to impairments in
daily activities.7,8 In PAD patients, aside from the
effects of aging, lower-extremity strength deficits
are associated with walking impairment,9 reduced
physical functioning, poor capacity for walking
faster, and reduced stair-climbing ability.3
Muscle function, which is related to physical
function and functional disability in subjects with
different clinical conditions, has been accurately
assessed with isokinetic dynamometers.7,10,11 In
PAD patients, isokinetic evaluation has also been
used,12e14 and the available evidence indicates
that PAD patients present lower isokinetic strength
and endurance in distal muscles compared with
age-matched control subjects.12e14 However,
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whether PAD affects muscle function in the prox-
imal muscles of the lower limbs remains unknown.
An understanding of the effects of PAD on proximal
muscle strength and endurance is important in the
development of interventions to improve muscle
function in these patients.
The aim of this study was to analyze the muscle
strength and endurance of the proximal and distal
lower-extremity muscles in PAD patients. We
hypothesize that PAD patients present with lower
muscle strength and endurance than control
patients in both the proximal and distal muscle
groups.
METHODS
Subjects
PatientswithandwithoutPADwere recruitedduring
regular visits to the Vascular Surgery and the Clinical
Geriatric Ambulatory departments, respectively, at
the Hospital das Clı´nicas of the School of Medicine
of the University of S~ao Paulo. PAD patients with
intermittent claudication (IC) were invited for
possible enrollment in a randomized controlled exer-
cise rehabilitation study for the treatment of claudi-
cation secondary to PAD. The data and analyses for
this study were part of the baseline assessments ob-
tained for the exercise study. The patients recruited
in the geriatric clinic (control subjects) were assessed
in regard to their physical limitations before invita-
tion to perform isokinetic testing.
Patients with PAD were included in the study if
they met the following criteria: Fontaine stage II
PAD,15 stable symptoms of IC for at least 6 months
with history of no revascularization in the previous
year, ankle-brachial index (ABI) at rest of 0.90 in
both legs,16 and exercise tolerance limited by IC
symptoms. The control patients were included if
they had no history of leg pain or other IC symptoms
and presented ABI of >1.0 in both legs. Both PAD
patients and control subjects were excluded under
the following conditions: presence of chronic lung
disease, inability to obtain ABI measurement, exer-
cise tolerance limited by dyspnea or orthopedic
problems, and the presence of an electrocardio-
graphic response during the exercise test suggestive
of myocardial ischemia.
Twenty patients with bilateral PAD and nine
control subjects were included. Strength and endur-
ance levels of the legs with higher and lower ABI in
PAD patients were compared, and no differences
between them were observed (P > 0.05). Thus, the
PAD group was composed of 40 legs, whereas the
control group was composed of 18 legs. This study
was approved by the Joint Committee on Ethics in
Research (n. 0758/08). All patients providedwritten
informed consent.
Clinical Evaluation
All subjects were evaluated by an experienced
vascular surgeon who obtained the ABI and local-
ized the obstruction by arterial palpation; these find-
ings were then confirmed using Doppler
ultrasonography measurements. The patients with
PAD performed a progressive graded treadmill test
to maximal claudication pain, as previously
described,17 to assess the claudication onset time
and peak walking time. In addition, a clinical
medical history of the subjects was obtained, as
previously described.17
Muscle Strength and Endurance
A Cybex 6000 isokinetic dynamometer (Cybex,
division of Lumex, Ronkonkoma, NY) was used
for isokinetic strength and endurance evaluations.
Before each test session, the isokinetic dyna-
mometer was calibrated in accordance with the
manufacturer specifications. Muscle strength was
obtained as the peak torque (PT), which represents
the highest single torque output achieved by
a muscle action through a range of motion. Muscle
endurance was assessed by the total work, which
represents the accumulated torque output
produced through a range of motion during several
repetitions.
The PAD patients and control subjects under-
went the same isokinetic evaluation protocol. Isoki-
netic strength and endurance testing were
performed in both legs in the knee (knee extension
and knee flexion) and ankle (dorsiflexion and
plantar flexion) joints. The evaluations started
with the ankle joint, followed by the knee joint.
For all subjects, the test started with the right leg,
as previously described.18
In the knee joint evaluation, the subjects were
seated at a 90 angle with the back support set.
Straps were fixed horizontally and diagonally across
the pelvis and the trunk, respectively. The lateral
femoral condyle was aligned with the dynamome-
ter’s rotation axis. The cuff of the force transducer
was placed proximal to the lateral malleoli. During
the ankle joint evaluation, the subjects remained
in the supine position, with the knee flexed at 45.
A pad was fixed under the thigh, and a thigh strap
was used for stabilization. The subject’s foot was
positioned such that the axis of rotation of the ankle
was aligned with the axis of rotation of the
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dynamometer. The foot was fixed to the footplate
with two straps, one strap distal to the ankle and
the second over the metatarsal bones.
To familiarize patients with the testing device, the
patients were instructed on the dynamometer
protocol and performed three to five unloaded
active repetitions of each movement, ranging from
maximal flexion to maximal extension. In all the
tests, the range of motion was set at 90. During
the knee joint evaluation, PT was determined with
a set of five maximal repetitions at an angular speed
of 60/sec, whereas the total work was obtained
with sets of 15 repetitions at an angular speed of
180/sec.
During the ankle joint evaluation, the PT was
determined with a set of five maximal repetitions
at an angular speed of 30/sec, whereas the total
work was evaluated in sets of eight repetitions at
an angular speed of 90/sec. The angular velocity
and the number of repetitions in each protocol
were determined based on previous studies.19,20
During all the tests, the patients were encouraged
to perform to their maximum effort and received
visual feedback through a monitor. The highest PT,
measured in newtons permeter (N/m),was adjusted
for body mass before analysis, as previously recom-
mended.21 The knee flexion/extension strength
ratio was determined by dividing the knee flexion
PT by the knee extension PT. Total work, measured
in joules (J), was used for analysis.
Statistical Analyses
The clinical characteristics of the subjects were
compared using Student t test for independent
samples for numerical variables and the c2 test for
categorical variables. PT and total work were
compared between groups with the Wilcoxon test.
Data of the patients clinical characteristics are pre-
sented as mean and standard deviation, and the
muscle strength and endurance data are presented
as the median and interquartile ranges. For all anal-
yses, the statistical significance was set at P < 0.05.
Analyses were performed using the statistical
package Statistica 6.0 (Statsoft, Tulsa, OK).
RESULTS
The clinical characteristics of the subjects are
described in Table I. The PAD group had higher
body weight, higher body mass index, and lower
ABI in both limbs compared with the control group
(P < 0.01). In addition, the prevalence of diabetes
mellitus and obesity differed between the two
groups (P < 0.05).
Compared with the control group, the PAD group
presented lower muscle strength (Fig. 1) in dorsiflex-
ion (0.20 ± 0.10 vs. 0.29 ± 0.10, P < 0.01), plantar
flexion (0.36 ± 0.20 vs. 0.53 ± 0.20, P < 0.01), and
knee flexion (0.50 ± 0.30 vs. 0.62 ± 0.10, P ¼ 0.04)
movements but similar strength in knee extension
Table I. General characteristics of the subjects
Variables PAD (n ¼ 20) Control (n ¼ 9) P
Age (yr) 64.8 ± 9.0 68.6 ± 10.3 0.34
Weight 73.2 ± 13.6 58.2 ± 8.4 <0.01
Height 1.61 ± 0.09 1.58 ± 0.11 0.37
BMI 27.5 ± 5.8 23.0 ± 2.0 <0.01
Gender (% men) 60.0 44.4 0.44
Clinical characteristics
ABI 0.44 ± 0.13 1.03 ± 0.08 <0.01
Claudication onset time (sec) 434 ± 265 e e
Total walking time (sec) 818 ± 349 e e
Iliofemoral obstruction (%) 15 e e
Femoropopliteal obstruction (%) 55 e e
Tibiofibular obstruction (%) 30 e e
Risk factors
Physical activity level (% inactive) 50 38 0.55
Actual smoker (%) 25 0 0.12
Hypertension (%) 90 63 0.09
Diabetes mellitus (%) 45 0 0.02
Obesity (%) 40 0 0.03
Heart disease (%) 25 0 0.12
PAD, peripheral artery disease; BMI, body mass index; ABI, ankle-brachial index.
Values are presented as means and standard deviations.
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movements (1.12 ± 0.60 vs. 1.22 ± 0.30, P ¼ 0.39).
The PAD group also presented a lower knee
flexion/extension strength ratio (Fig. 2) than the
control group (47.0 ± 17.0 vs. 53.0 ± 6.0, P < 0.05).
Compared with the control group, the PAD
group presented with lower muscle endurance
(Fig. 3) in dorsiflexion (8.0 ± 3.5 vs. 9.9 ± 6.6,
P ¼ 0.01) and plantar flexion (20.0 ± 9.0 vs. 25.7 ±
10.7, P ¼ 0.02) movements but similar endurance
in knee flexion (27.0 ± 21.5 vs. 27.5 ± 8.3,
P ¼ 0.94) and knee extension (57.0 ± 29.0 vs.
49.7 ± 9.1, P ¼ 0.12) movements.
DISCUSSION
The major findings of this study were that PAD
patients presented lower dorsiflexion, plantar
flexion, and knee flexion muscle strength; lower
dorsiflexion and plantar flexion muscle endurance;
and a lower agonist/antagonist ratio compared
with control patients without PAD.
The evaluation of the distal muscle in PAD
patients is important, given the predominantly
distal nature of the arterial impairment observed
in these individuals. In the present study, the PAD
patients presented a >20% decrease in muscle
strength in the distal muscles comparedwith control
subjects. Regensteiner et al.22 compared the PT in
plantar flexion and dorsiflexion movements among
PAD patients and age-matched control subjects,
reporting strength deficits of >20%. These results
are also in agreement with other studies,13,23 and
these deficits are mainly caused by neuromuscular
dysfunctions, such as denervation, nerve impair-
ment, apoptosis, and muscle atrophy, which have
been adequately described in the distal muscles of
PAD patients.24
The evaluation of proximal strength in the lower-
limb muscles is important, considering their rele-
vant contribution to mobility.23 The novelty of the
present study is that the knee flexion strength was
17.0% lower in PAD patients comparedwith control
subjects. As a result, the agonist/antagonist ratio
was 14.0% lower in the PAD patients, indicating
Fig. 1. Proximal and distal muscle strength in peripheral artery disease (PAD) patients (n ¼ 40 legs) and control
subjects (n ¼ 18 legs). *Significantly different from the control group (P < 0.05).
Fig. 2. Knee flexion/extension ratio in PAD patients
(n ¼ 40 legs) and control subjects (n ¼ 18 legs). *Signif-
icantly different from the control group (P < 0.05).
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that these patients present an imbalance between
anterior and posterior thigh strength. Gardner and
Montgomery25 reported that PAD patients pre-
sented an 86% higher frequency of a history of
stumbling and imbalance and a 73% higher
frequency of a history of falling than age-matched
control subjects. Because co-contraction of the
antagonist muscles has been proposed as an impor-
tant mechanism tomaintain balance and protect the
joint from injury,26 our results suggest that reduced
knee flexion strength might be involved in the
higher prevalence of falls among PAD patients,
which should be investigated in future studies.
The results of the present study revealed that PAD
patients present lower muscle endurance in the
distal muscles compared with control patients. The
reduced endurance in the distal muscle groups in
PAD patients has been well described13,22 andmight
reflect mitochondrial impairment27 and the failure
of the arterial system to maintain adequate blood
flow and consequent oxygen delivery to distal
regions of the arterial obstruction during a muscle
contraction, which maintains the aerobic nature of
the activity. In the present study, 80% of patients
presented with distal obstructions (femoropopliteal
or popliteal-tibial). However, the muscle endurance
of the proximal muscles was similar between PAD
patients and control subjects, probably because the
arterial obstruction did not affect the muscle supply
to the proximal muscles in most patients.
The clinical application of this study is that inter-
ventions to reverse strength deficits in both the
proximal and distal muscle groups should be consid-
ered in PAD patients. It is well established that
walking exercise training and/or surgical interven-
tion improves walking capacity and muscle endur-
ance1; however, these interventions are not
effective in improving muscle strength. Therefore,
it is recommended that interventions to improve
muscle strength, such as resistance training,28
should also be prescribed for these patients. Our
results also suggest that interventions should target
the improvement of muscle balance between
extensor and flexor muscles in the knee, which
might help to avoid the risk of fall among the PAD
patients.
This study has several limitations that have to be
taken into account. The cross-sectional design does
not allow causality to be established. The recruit-
ment of the sample was intentional, and the poten-
tial selection bias cannot be disregarded. In
particular, the control subjects were not recruited
to an intervention study but the PAD patients
were, which explains the difference in the number
of patients in each group. Moreover, the order of
the tests was not randomized, and accumulated
fatigue might have impacted the final exercises.
Finally, in the present study, there were more obese
and diabetic patients in the PAD group than in the
control group and this might have influenced the
Fig. 3. Proximal and distal muscle endurance in PAD patients (n ¼ 40 legs) and control subjects (n ¼ 18 legs). *Signif-
icantly different from the control group (P < 0.05).
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results of this study. However, it is important to
highlight that the prevalence of those comorbid
conditions is higher in PAD patients, which
increases the external validity of the present study.
In conclusion, the results of this study showed
that PAD patients presented with lower proximal
and distalmuscle strength, lower endurance in distal
muscles, and lower agonist/antagonist ratio
comparedwith control subjectswithout PAD. There-
fore, it is recommended that interventions to
improve muscle strength in the proximal and distal
muscle groups shouldbeprescribed for PADpatients.
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